SynthesisFrontiers in immunology2023

Cerebrospinal fluid inflammatory biomarkers for disease progression in Alzheimer's disease and multiple sclerosis: a systematic review.

Joke Temmerman et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.